xRead - Recurrent Respiratory Papillomatosis (October 2025)

First page Table of contents Next page Last page
Article 1 - A Consensus Statement on the Administration of Systemic Bevacizumab in Patients with Recurrent Respiratory Papillomatosis1
Article 2 - DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-31077
Article 3 - Significant Declines in Juvenile-onset Recurrent Respiratory Papillomatosis Following Human Papillomavirus (HPV) Vaccine Introduction in the United States23
Article 4 - International Pediatric Otolaryngology Group (IPOG): Juvenile-onset recurrent respiratory papillomatosis consensus recommendations35
Article 5 - Recurrent respiratory papillomatosis: comparing in-office and operating room treatments44

Made with FlippingBook - professional solution for displaying marketing and sales documents online